1,728 research outputs found
Spectral Graph Convolutions for Population-based Disease Prediction
Exploiting the wealth of imaging and non-imaging information for disease
prediction tasks requires models capable of representing, at the same time,
individual features as well as data associations between subjects from
potentially large populations. Graphs provide a natural framework for such
tasks, yet previous graph-based approaches focus on pairwise similarities
without modelling the subjects' individual characteristics and features. On the
other hand, relying solely on subject-specific imaging feature vectors fails to
model the interaction and similarity between subjects, which can reduce
performance. In this paper, we introduce the novel concept of Graph
Convolutional Networks (GCN) for brain analysis in populations, combining
imaging and non-imaging data. We represent populations as a sparse graph where
its vertices are associated with image-based feature vectors and the edges
encode phenotypic information. This structure was used to train a GCN model on
partially labelled graphs, aiming to infer the classes of unlabelled nodes from
the node features and pairwise associations between subjects. We demonstrate
the potential of the method on the challenging ADNI and ABIDE databases, as a
proof of concept of the benefit from integrating contextual information in
classification tasks. This has a clear impact on the quality of the
predictions, leading to 69.5% accuracy for ABIDE (outperforming the current
state of the art of 66.8%) and 77% for ADNI for prediction of MCI conversion,
significantly outperforming standard linear classifiers where only individual
features are considered.Comment: International Conference on Medical Image Computing and
Computer-Assisted Interventions (MICCAI) 201
Development of Gaussian Learning Algorithms for Early Detection of Alzheimer\u27s Disease
Alzheimerās disease (AD) is the most common form of dementia affecting 10% of the population over the age of 65 and the growing costs in managing AD are estimated to be $259 billion, according to data reported in the 2017 by the Alzheimer\u27s Association. Moreover, with cognitive decline, daily life of the affected persons and their families are severely impacted. Taking advantage of the diagnosis of AD and its prodromal stage of mild cognitive impairment (MCI), an early treatment may help patients preserve the quality of life and slow the progression of the disease, even though the underlying disease cannot be reversed or stopped. This research aims to develop Gaussian learning algorithms, natural language processing (NLP) techniques, and mathematical models to effectively delineate the MCI participants from the cognitively normal (CN) group, and identify the most significant brain regions and patterns of changes associated with the progression of AD. The focus will be placed on the earliest manifestations of the disease (early MCI or EMCI) to plan for effective curative/therapeutic interventions and protocols.
Multiple modalities of biomarkers have been found to be significantly sensitive in assessing the progression of AD. In this work, several novel multimodal classification frameworks based on proposed Gaussian Learning algorithms are created and applied to neuroimaging data. Classification based on the combination of structural magnetic resonance imaging (MRI), positron emission tomography (PET), and cerebrospinal fluid (CSF) biomarkers is seen as the most reliable approach for high-accuracy classification.
Additionally, changes in linguistic complexity may provide complementary information for the diagnosis and prognosis of AD. For this research endeavor, an NLP-oriented neuropsychological assessment is developed to automatically analyze the distinguishing characteristics of text data in MCI group versus those in CN group. Early findings suggest significant linguistic differences between CN and MCI subjects in terms of word usage, vocabulary, recall, fragmented sentences.
In summary, the results obtained indicate a high potential of the neuroimaging-based classification and NLP-oriented assessment to be utilized as a practically computer aided diagnosis system for classification and prediction of AD and its prodromal stages. Future work will ultimately focus on early signs of AD that could help in the planning of curative and therapeutic intervention to slow the progression of the disease
Identification of gene pathways implicated in Alzheimer's disease using longitudinal imaging phenotypes with sparse regression
We present a new method for the detection of gene pathways associated with a
multivariate quantitative trait, and use it to identify causal pathways
associated with an imaging endophenotype characteristic of longitudinal
structural change in the brains of patients with Alzheimer's disease (AD). Our
method, known as pathways sparse reduced-rank regression (PsRRR), uses group
lasso penalised regression to jointly model the effects of genome-wide single
nucleotide polymorphisms (SNPs), grouped into functional pathways using prior
knowledge of gene-gene interactions. Pathways are ranked in order of importance
using a resampling strategy that exploits finite sample variability. Our
application study uses whole genome scans and MR images from 464 subjects in
the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. 66,182 SNPs
are mapped to 185 gene pathways from the KEGG pathways database. Voxel-wise
imaging signatures characteristic of AD are obtained by analysing 3D patterns
of structural change at 6, 12 and 24 months relative to baseline. High-ranking,
AD endophenotype-associated pathways in our study include those describing
chemokine, Jak-stat and insulin signalling pathways, and tight junction
interactions. All of these have been previously implicated in AD biology. In a
secondary analysis, we investigate SNPs and genes that may be driving pathway
selection, and identify a number of previously validated AD genes including
CR1, APOE and TOMM40
- ā¦